Morningstar Investor users sign in here.

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel 4070
    CHE

    T: +41 616881111

    E: investor.relations@roche.com

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

6 undervalued stocks with low beta

Berkshire Hathaway and Verizon are among the low-volatility stocks that trade at a discount.
video

An undervalued, wide-moat name in healthcare

Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,995.70 23.70 -0.30%
CAC 40 8,222.47 13.19 0.16%
DAX 40 18,714.64 27.58 -0.15%
Dow JONES (US) 39,471.51 40.00 0.10%
FTSE 100 8,437.78 22.79 0.27%
HKSE 19,073.71 41.35 -0.22%
NASDAQ 16,418.71 30.47 0.19%
Nikkei 225 38,356.06 176.60 0.46%
NZX 50 Index 11,618.09 34.07 -0.29%
S&P 500 5,227.26 5.84 0.11%
S&P/ASX 200 7,726.80 23.20 -0.30%
SSE Composite Index 3,145.77 2.25 -0.07%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.05 0.01 12.20%
Pantoro Ltd PNR 0.08 0.01 -6.98%
Telstra Group Ltd TLS 3.65 0.02 -0.55%
Pilbara Minerals Ltd PLS 3.97 0.11 -2.70%
Alumina Ltd AWC 1.71 0.11 6.88%
Imugene Ltd IMU 0.07 0.00 0.00%
South32 Ltd S32 3.62 0.01 0.28%
Carnarvon Energy Ltd CVN 0.22 0.01 2.38%
Red 5 Ltd RED 0.48 0.01 2.15%
Jupiter Mines Ltd JMS 0.37 0.01 -1.35%